Condition: Pulmonary Disease, Chronic Obstructive (COPD) · Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
The objective of the study was to evaluate the efficacy and safety of 611 in Chinese adults with moderate to severe COPD.
This description comes directly from the study's public registry record.
Qinghong Zhou, Master · +86 18911301578 · zhouqinghong@3sbio.com
Always discuss trial participation with your own doctor first.
| China-Japan Friendship Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Shenzhen People's Hospital | Shenzhen, Guangdong, China | Recruiting |
| Jiangsu Province Hospital | Nanjing, Jiangsu, China | Recruiting |
| ZheJiang Provincial People's Hospital | Hangzhou, Zhejiang, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07039669